Key Takeaways * No medication is 100% risk-free during pregnancy. Every decision requires a careful risk-benefit conversation with your healthcare provider. * Your personal risk from a medication is not universal. It is heavily influenced by your unique genetic makeup, specifically the genes that control how your body metabolizes drugs. * Pharmacogenetic (PGx)

Key Takeaways * Recent studies have suggested a correlation between frequent acetaminophen (Tylenol) use during pregnancy and a higher risk of ADHD and autism in children, causing understandable concern for parents. * The key takeaway from this news is not that Tylenol is universally dangerous, but that an individual's risk

In modern medicine, the pressure on clinicians has never been greater. Patient complexity is increasing, time is always limited, and the demand for evidence-based, personalized care is the new benchmark. While we have more therapeutic options than ever, the fundamental challenge of prescribing remains: how can we be confident that

It’s a question more clinicians are hearing in their practice: “I think I have the MTHFR mutation. What does that mean for my health?” Driven by direct-to-consumer genetic testing and online health forums, patients are increasingly aware of the MTHFR gene. While this awareness can lead to confusion, it

Prescribing psychiatric medication for a child or adolescent is one of the most considered decisions a clinician can make. The responsibility is immense, and the process is often fraught with uncertainty for providers, parents, and the young patients themselves. Unlike in adult medicine, you are working with a developing system

For any clinician managing patients with co-morbid conditions, polypharmacy is the norm. It’s a delicate balancing act of therapeutic goals, but each new prescription added to the regimen increases the risk of a cascade of negative outcomes: drug-drug interactions, adverse drug reactions (ADRs), and therapeutic failures. Standard interaction checkers

The clinical mantra of "start low, go slow" has long guided prescribing, but it's an approach born from necessity, not precision. It’s a tacit acknowledgment that patients metabolize medications at vastly different rates. What if you could know a patient's metabolic capacity before

Introduction As a provider, you understand that every patient responds differently to treatment—especially when it comes to medications. Whether managing depression, anxiety, ADHD, chronic pain, or cardiovascular conditions, the challenge remains the same: finding the right medication at the right dose, without unnecessary trial and error. Pharmacogenetic (PGx) testing

Introduction Pharmacogenetic (PGx) testing delivers powerful insights—but interpreting those insights and translating them into patient care decisions can sometimes raise some questions, especially for providers new to PGx. At ClarityX®, we believe clinical support shouldn’t end when the report is delivered. That’s why every provider who orders

Introduction When it comes to pharmacogenetic (PGx) testing, the provider’s intent is simple: identify the right medication for the patient based on their genetic profile. But the path to achieving that goal can vary dramatically depending on the lab you choose. If you’ve ever ordered a PGx test

Introduction: Pharmacogenetic (PGx) testing is a valuable clinical tool—but knowing when to use it and with whom is just as important as understanding how it works. Many providers recognize the benefits of personalized prescribing but aren’t always sure which patients will benefit most from PGx testing. This insight